Agree, and this has reached point of why we invested in ResAppDx in the first place.....and I not sure about P&D, I think revenue will come quick and fast (only need a catalyst IMO) especially with the awareness around respiratory tract infection after COVID-19.
Ann: Agreement with Ilara Health to sell ResAppDx in Kenya, page-217
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)